Preclinical imaging: An essential ally in modern biosciences

Molecular Diagnosis and Therapy

Volumn 18, Issue 2, 2014, Pages 153-173

  Cunha, Lídia ^a,b,c   Horvath, Ildiko ^d   Ferreira, Sara ^a   Lemos, Joana ^a   Costa, Pedro ^a   Vieira, Domingos ^a   Veres, Dániel S ^d   Szigeti, Krisztián ^d   Summavielle, Teresa ^b   Máthé, Domokos ^e   Metello, Luís F ^a,f  

^a POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e CROmed Ltd   (Hungary)

^f IsoPor   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; FLUORINE 18; GALLIUM 67; GALLIUM 68; INDIUM 111; IODINE 123; IODINE 124; IODINE 131; NITROGEN 13; OXYGEN 15; RADIOISOTOPE; RUBIDIUM 82; TECHNETIUM 99M; THALLIUM 201; UNCLASSIFIED DRUG; ZIRCONIUM 89;

ANIMAL MODEL; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; CARDIOLOGY; CLINICAL RESEARCH; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG INDUSTRY; ECHOGRAPHY; FLUORESCENCE IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; INFECTION; INTERMETHOD COMPARISON; MICRO-COMPUTED TOMOGRAPHY; MICRO-NUCLEAR MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; NEUROLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR MEDICINE; ONCOLOGY; PATHOPHYSIOLOGY; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRE-CLINICAL IMAGING DEVICE; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECT SCANNER; TRANSLATIONAL RESEARCH; TREATMENT RESPONSE;

ANIMALS; DIAGNOSTIC IMAGING; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MODELS, ANIMAL; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84897397513     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.1007/s40291-013-0062-3     Document Type: Review

References (138)

1. Milne CP, Kaitin KI. Translational medicine: an engine of change for bringing new technology to community health. Sci Transl Med. 2009 Nov 4;1(5):5cm5.
2. Lewis JS, Achilefu S, Garbow JR, Laforest R, Welch MJ. Small animal imaging: current technology and perspectives for oncological imaging. Eur J Cancer. 2002;38(16):2173-88. (Pubitemid 35223252)
3. Franc BL, Acton PD, Mari C, Hasegawa BH. Small-animal SPECT and SPECT/CT: important tools for preclinical investigation. J Nucl Med. 2008;49(10):1651-63.
4. Allport JR, Weissleder R. In vivo imaging of gene and cell therapies. Exp Hematol. 2001;29(11):1237-46. (Pubitemid 33033300)
5. Pomper MG, Lee JS. Small animal imaging in drug development. Curr Pharm Des. 2005;11(25):3247-72. (Pubitemid 41300775)
6. Deng WP, Wu CC, Lee CC, Yang WK, Wang HE, Liu RS, et al. Serial in vivo imaging of the lung metastases model and gene therapy using HSV1-tk and ganciclovir. J Nucl Med. 2006;47(5):877-84. (Pubitemid 46768452)
7. Turetschek K, Floyd E, Helbich T, Roberts TP, Shames DM, Wendland MF, et al. MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology. J Magn Reson Imaging. 2001;14(3):237-42. (Pubitemid 32801057)
8. Cheng Z, Mahmood A, Li H, Davison A, Jones AG. [99mTcOAADT]-(CH2)2-NEt2: a potential small-molecule single-photon emission computed tomography probe for imaging metastatic melanoma. Cancer Res. 2005;65(12):4979-86. (Pubitemid 40827301)
9. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med. 2001;42(5 Suppl):1S-93S. (Pubitemid 32423895)
10. Bading JR, Shields AF. Imaging of cell proliferation: status and prospects. J Nucl Med. 2008;49(Suppl 2):64S-80S. (Pubitemid 351948037)
11. Blasberg R. PET imaging of gene expression. Eur J Cancer. 2002;38(16):2137-46. (Pubitemid 35229989)
12. Gambhir SS, Herschman HR, Cherry SR, Barrio JR, Satyamurthy N, Toyokuni T, et al. Imaging transgene expression with radionuclide imaging technologies. Neoplasia. 2000;2(1-2):118-38. (Pubitemid 30123184)
13. Orlova A, Nilsson FY, Wikman M, Widstrom C, Stahl S, Carlsson J, et al. Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors. J Nucl Med. 2006;47(3):512-9. (Pubitemid 46768494)
14. Foss CA, Mease RC, Fan H, Wang Y, Ravert HT, Dannals RF, et al. Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer. Clin Cancer Res. 2005;11(11):4022-8. (Pubitemid 40791565)
15. Haubner RH, Wester HJ, Weber WA, Schwaiger M. Radiotracer-based strategies to image angiogenesis. Q J Nucl Med. 2003;47(3):189-99. (Pubitemid 37279155)
16. Jia B, Shi J, Yang Z, Xu B, Liu Z, Zhao H, et al. 99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin alphavbeta3 expression. Bioconjugate Chem. 2006;17(4):1069-76. (Pubitemid 44162628)
17. Niu G, Chen X. PET imaging of angiogenesis. PET Clin. 2009;4(1):17-38.
18. Holland JP, Lewis JS, Dehdashti F. Assessing tumor hypoxia by positron emission tomography with Cu-ATSM. Q J Nucl Med Mol Imag. 2009;53(2):193-200.
19. Madar I, Huang Y, Ravert H, Dalrymple SL, Davidson NE, Isaacs JT, et al. Detection and quantification of the evolution dynamics of apoptosis using the PET voltage sensor 18F-fluorobenzyl triphenyl phosphonium. J Nucl Med. 2009;50(5):774-80.
20. Murakami Y, Takamatsu H, Taki J, Tatsumi M, Noda A, Ichise R, et al. 18F-labelled annexin V: a PET tracer for apoptosis imaging. Eur J Nucl Med Mol Imag. 2004;31(4):469-74. (Pubitemid 38461560)
21. Jaffer FA, Weissleder R. Seeing within: molecular imaging of the cardiovascular system. Circ Res. 2004;94(4):433-45. (Pubitemid 38326278)
22. Lamb HJ, van der Meer RW, de Roos A, Bax JJ. Cardiovascular molecular MR imaging. Eur J Nucl Med Mol Imag. 2007; 34(Suppl 1):S99-104.
23. Hua J, Dobrucki LW, Sadeghi MM, Zhang J, Bourke BN, Cavaliere P, et al. Noninvasive imaging of angiogenesis with a 99mTc-labeled peptide targeted at alphavbeta3 integrin after murine hindlimb ischemia. Circulation. 2005;111(24):3255-60. (Pubitemid 40874998)
24. Khaw BA, Tekabe Y, Johnson LL. Imaging experimental atherosclerotic lesions in ApoE knockout mice: enhanced targeting with Z2D3-anti-DTPA bispecific antibody and 99mTc-labeled negatively charged polymers. J Nucl Med. 2006;47(5):868-76. (Pubitemid 46768451)
25. Kolodgie FD, Petrov A, Virmani R, Narula N, Verjans JW, Weber DK, et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation. 2003;108(25):3134-9. (Pubitemid 38031804)
26. Schafers M, Riemann B, Kopka K, Breyholz HJ, Wagner S, Schafers KP, et al. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation. 2004; 109(21):2554-9. (Pubitemid 38720556)
27. Acton PD, Kung HF. Small animal imaging with high resolution single photon emission tomography. Nucl Med Biol. 2003;30(8):889-95. (Pubitemid 38040998)
28. Lancelot S, Zimmer L. Small-animal positron emission tomography as a tool for neuropharmacology. Trend Pharmacol Sci. 2010;31(9):411-7.
29. Zanzonico P. Noninvasive imaging for supporting basic research. In: Kiessling F, Pichler BJ, editors. Small animal imaging-basics and practical guide. Heidelberg: Springer; 2011. p. 3-16.
30. Kagadis GC, Loudos G, Katsanos K, Langer SG, Nikiforidis GC. In vivo small animal imaging: current status and future prospects. Med Phys. 2010;37(12):6421-42.
31. Weissleder R, Mahmood U. Molecular imaging. Radiology. 2001;219(2):316-33. (Pubitemid 32336342)
32. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 2003;17(5):545-80. (Pubitemid 36307540)
33. Grassi R, Lagalla R, Rotondo A. Genomics, proteomics, MEMS and SAIF: which role for diagnostic imaging? La Radiologia medica. 2008;113(6):775-8.
34. Alberti C. From molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapy. Eur Rev Med Pharmacol Sci. 2012;16(14):1925-33.
35. Meikle SR, Kench P, Kassiou M, Banati RB. Small animal SPECT and its place in the matrix of molecular imaging technologies. Phys Med Biol. 2005;50(22):R45-61. (Pubitemid 41566715)
36. Peterson TE, Shokouhi S. Advances in preclinical SPECT instrumentation. J Nucl Med. 2012;53(6):841-4.
37. Khalil MM, Tremoleda JL, Bayomy TB, Gsell W. Molecular SPECT imaging: an overview. Int J Mol Imaging. 2011;2011:796025.
38. Peterson TE, Furenlid LR. SPECT detectors: the Anger Camera and beyond. Phys Med Biol. 2011;56(17):R145-82.
39. Kim H, Furenlid LR, Crawford MJ, Wilson DW, Barber HB, Peterson TE, et al. SemiSPECT: a small-animal single-photon emission computed tomography (SPECT) imager based on eight cadmium zinc telluride (CZT) detector arrays. Med Phys. 2006;33(2):465-74. (Pubitemid 43183991)
40. Phelps ME. Positron emission tomography provides molecular imaging of biological processes. Proc Nat Acad Sci USA. 2000;97(16):9226-33. (Pubitemid 30627544)
41. Phelps ME. PET: the merging of biology and imaging into molecular imaging. J Nucl Med. 2000;41(4):661-81. (Pubitemid 30207744)
42. Kowalski J, Henze M, Schuhmacher J, Mäcke HR, Hofmann M, Haberkorn U. Evaluation of Positron Emission Tomography Imaging Using [68 Ga]-DOTA-D Phe1-Tyr3-Octreotide in Comparison to [111In]-DTPAOC SPECT. First Results in Patients with Neuroendocrine Tumors. Mol Imaging Biol. 2003;5(1):42-8. (Pubitemid 36596544)
43. Holland JP, Sheh Y, Lewis JS. Standardized methods for the production of high specific-activity zirconium-89. Nucl Med Biol. 2009;36(7):729-39.
44. Basu S, Urhan M, Rosenbaum J, Alavi A. PET and PET/CT in the management of thyroid cancer. Method Mol Biol. 2011;727:205-24.
45. Fass L. Imaging and cancer: a review. Mol Oncol. 2008; 2(2):115-52.
46. Levin CS, Zaidi H. Current trends in preclinical PET system design. PET Clin. 2007;2(2):125-60.
47. Yao R, Lecomte R, Crawford ES. Small-animal PET: what is it, and why do we need it? J Nucl Med Technol. 2012 Sep;40(3):157-65.
48. Hutchins GD, Miller MA, Soon VC, Receveur T. Small animal PET imaging. ILAR J. 2008;49(1):54-65.
49. Lecomte R. Technology challenges in small animal PET imaging. Nucl Instrum Methods Phys Res A. 2004;527(1-2):157-65.
50. Comley J. In vivo preclinical imaging: an essential tool in translational research. Drug Discovery World. 2011:58-71.
51. Beekman F, van der Have F. The pinhole: gateway to ultra-high-resolution three-dimensional radionuclide imaging. Eur J Nucl Med Mol Imaging. 2007;34(2):151-61. (Pubitemid 46147496)
52. Shao Y, Cherry SR, Farahani K, Slates R, Silverman RW, Meadors K, et al. Development of a PET detector system compatible with MRI/NMR systems. IEEE Trans Nucl Sci. 1997;44(3):1167-71. (Pubitemid 127827068)
53. Tsui BM, Kraitchman DL. Recent advances in small-animal cardiovascular imaging. J Nucl Med. 2009;50(5):667-70.
54. de Kemp RA, Epstein FH, Catana C, Tsui BM, Ritman EL. Small-animal molecular imaging methods. J Nucl Med. 2010; 1(51 Suppl 1):18S-32S.
55. Fleming JS, Alaamer AS. Influence of collimator characteristics on quantification in SPECT. J Nucl Med. 1996;37(11):1832-6. (Pubitemid 26378374)
56. Chatziioannou AF, Cherry SR, Shao Y, Silverman RW, Meadors K, Farquhar TH, et al. Performance evaluation of micro-PET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging. J Nucl Med. 1999;40(7):1164-75. (Pubitemid 29315509)
57. Levin CS, Hoffman EJ. Calculation of positron range and its effect on the fundamental limit of positron emission tomography system spatial resolution. Phys Med Biol. 1999;44(3):781.
58. Tai YC, Ruangma A, Rowland D, Siegel S, Newport DF, Chow PL, et al. Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging. J Nucl Med. 2005;46(3):455-63. (Pubitemid 43093155)
59. Beekman FJ, van der Have F, Vastenhouw B, van der Linden AJ, van Rijk PP, Burbach JP, et al. U-SPECT-I: a novel system for submillimeter-resolution tomography with radiolabeled molecules in mice. J Nucl Med. 2005;46(7):1194-200. (Pubitemid 43741082)
60. Vastenhouw B, Beekman F. Submillimeter total-body murine imaging with U-SPECT-I. J Nucl Med. 2007;48(3):487-93. (Pubitemid 47604935)
61. Chatziioannou AF. Instrumentation for molecular imaging in preclinical research: Micro-PET and Micro-SPECT. Proc Am Thorac Soc. 2005;2(6):533-6, 10-11.
62. Henriksen G, Drzezga A. Imaging in neurology research II: PET imaging in CNS disorders. In: Kiessling F, Pichler BJ, editors. Small animal imaging-basics and practical guide. Heidelberg: Springer; 2011. p. 499-513.
63. Hume SP, Gunn RN, Jones T. Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals. Eur J Nucl Med. 1998;25(2):173-6. (Pubitemid 28130042)
64. Judenhofer MS, Wiehr S, Kukuk D, Fischer K, Pichler BJ. Guidelines for nuclear image analysis. In: Kiessling F, Pichler BJ, editors. Small animal imaging-basics and practical guide. Heidelberg: Springer; 2011. p. 379-86.
65. Cavanaugh D, Johnson E, Price RE, Kurie J, Travis EL, Cody DD. In vivo respiratory-gated micro-CT imaging in small-animal oncology models. Mol Imaging. 2004;3(1):55-62.
66. Ritman EL. Current status of developments and applications of micro-CT. Annu Rev Biomed Eng. 2011;15(13):531-52.
67. Badea CT, Drangova M, Holdsworth DW, Johnson GA. In vivo small-animal imaging using micro-CT and digital subtraction angiography. Phys Med Biol. 2008;53(19):R319-50.
68. Lee N, Choi SH, Hyeon T. Nano-sized CT contrast agents. Adv Mater. 2013;25(19):2641-60.
69. Pietsch H. CT contrast agents. In: Kiessling F, Pichler BJ, editors. Small animal imaging-basics and practical guide. Heidelberg: Springer; 2011. p. 141-9.
70. Kalender WA, Deak P, Engelke K, Karolczak M. X-ray and X-ray CT. In: Kiessling F, Pichler BJ, editors. Small animal imaging-basics and practical guide. Heidelberg: Springer; 2011. p. 125-39.
71. Dufort S, Sancey L, Wenk C, Josserand V, Coll JL. Optical small animal imaging in the drug discovery process. Biochim Biophys Acta. 2010;1798(12):2266-73.
72. Tremoleda JL, Khalil M, Gompels LL, Wylezinska-Arridge M, Vincent T, Gsell W. Imaging technologies for preclinical models of bone and joint disorders. EJNMMI Res. 2011;1(1):11.
73. Koba W, Kim K, Lipton ML, Jelicks L, Das B, Herbst L, et al. Imaging devices for use in small animals. Semin Nucl Med. 2011;41(3):151-65.
74. Jakob P. Small animal magnetic resonance imaging: basic principles, instrumentation and practical issues. In: Kiessling F, Pichler BJ, editors. Small animal imaging-basics and practical guide. Heidelberg: Springer; 2011. p. 151-64.
75. Brockmann MA. Use of clinical MR scanners for small rodent imaging. Methods. 2007;43(1):1. (Pubitemid 47285735)
76. Leroy-Willig A, Geldwerth-Feniger G. Nuclear magnetic resonance imaging and spectroscopy. In: Ntziachristos V, Leroy-Willig A, Tavitian B, editors. Textbook of in vivo imaging in vertebrates. UK: Wiley; 2007. p. 1-56.
77. Weber WA, Kiessling F. Imaging in oncology research. In: Kiessling F, Pichler BJ, editors. Small animal imaging-basics and practical guide. Heidelberg: Springer; 2011. p. 543-64.
78. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology. 2000;217(2):331-45.
79. Heeger DJ, Ress D. What does fMRI tell us about neuronal activity? Nat Rev Neurosci. 2002;3(2):142-51. (Pubitemid 135706583)
80. Goetti R, O'Gorman R, Khan N, Kellenberger CJ, Scheer I. Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI. Neuroradiology. 2013;55(5):639-47.
81. Cutajar M, Thomas DL, Banks T, Clark CA, Golay X, Gordon I. Repeatability of renal arterial spin labelling MRI in healthy subjects. MAGMA. 2012;25(2):145-53.
82. Thomas D, Wells J. MR angiography and arterial spin labelling. Method Mol Biol. 2011;711:327-45.
83. Kazan SM, Chappell MA, Payne SJ. Modelling the effects of cardiac pulsations in arterial spin labelling. Phys Med Biol. 2010;55(3):799-816.
84. Richards TL. Multinuclear Magnetic Resonance Spectroscopic Imaging. Encyclopedia of Analytical Chemistry. New York: Wiley; 2006.
85. Rudin M. Imaging techniques. Molecular imaging: basic principles and applications in biomedical research. London: Imperial College Press; 2005. p. 45-140.
86. Rosen Y, Lenkinski RE. Recent advances in magnetic resonance neurospectroscopy. Neurotherapeutics. 2007;4(3):330-45. (Pubitemid 46962408)
87. Gujar SK, Maheshwari S, Bjorkman-Burtscher I, Sundgren PC. Magnetic resonance spectroscopy. J Neuroophthalmol. 2005; 25(3):217-26. (Pubitemid 41306683)
88. van der Graaf M. In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. Eur Biophys J. 2010;39(4):527-40.
89. Zhu H, Barker PB. MR spectroscopy and spectroscopic imaging of the brain. Methods Mol Biol. 2011;711:203-26.
90. Forster D, Davies K, Williams S. Magnetic resonance spectroscopy in vivo of neurochemicals in a transgenic model of Alzheimer's disease: a longitudinal study of metabolites, relaxation time, and behavioral analysis in TASTPM and wildtype mice. Magn Reson Med. 2013;69(4):944-55.
91. He Q, Xu RZ, Shkarin P, Pizzorno G, Lee-French CH, Rothman DL, et al. Magnetic resonance spectroscopic imaging of tumor metabolic markers for cancer diagnosis, metabolic phenotyping, and characterization of tumor microenvironment. Dis Markers. 2003;19(2-3):69-94. (Pubitemid 38530354)
92. Bremer C, Ntziachristos V, Weissleder R. Optical-based molecular imaging: contrast agents and potential medical applications. Eur Radiol. 2003;13(2):231-43. (Pubitemid 36798598)
93. Chin PT, Welling MM, Meskers SC, Valdes Olmos RA, Tanke H, van Leeuwen FW. Optical imaging as an expansion of nuclear medicine: Cerenkov-based luminescence vs fluorescence-based luminescence. Eur J Nucl Med Mol Imaging. 2013; 40(8):1283-91.
94. Wilson T, Hastings J. Bioluminescence. Annu Rev Cell Dev Biol. 1988;14:197-230.
95. Greer LF III, Szalay AA. Imaging of light emission from the expression of luciferases in living cells and organisms: a review. Luminescence. 2002;17(1):43-74.
96. Weissleder R. Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer. 2002;2(1):11-8. (Pubitemid 37328803)
97. Culver J, Akers W, Achilefu S. Multimodality molecular imaging with combined optical and SPECT/PET modalities. J Nucl Med. 2008;49(2):169-72. (Pubitemid 351225675)
98. Ntziachristos V, Bremer C, Weissleder R. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol. 2003;13(1):195-208. (Pubitemid 36790510)
99. Kruger RA. Photoacoustic ultrasound. Med Phys. 1994;21(1):127-31. (Pubitemid 24056506)
100. Wang LV, Hu S. Photoacoustic tomography: in vivo imaging from organelles to organs. Science. 2012;335(6075):1458-62.
101. Robertson R, Germanos MS, Li C, Mitchell GS, Cherry SR, Silva MD. Optical imaging of Cerenkov light generation from positron-emitting radiotracers. Phys Med Biol. 2009;54(16):N355-65.
102. Liu H, Ren G, Miao Z, Zhang X, Tang X, Han P, et al. Molecular optical imaging with radioactive probes. PloS One. 2010;5(3):e9470.
103. Spinelli AE, Ferdeghini M, Cavedon C, Zivelonghi E, Calandrino R, Fenzi A, et al. First human Cerenkography. J Biomed Opt. 2013;18(2):20502.
104. Vooijs M, Jonkers J, Lyons S, Berns A. Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res. 2002;62(6):1862-7. (Pubitemid 34408514)
105. Liang HD, Blomley MJ. The role of ultrasound in molecular imaging. British J Radiol. 2003;76 Spec No 2:S140-50. (Pubitemid 39530307)
106. Coatney RW. Ultrasound imaging: principles and applications in rodent research. ILAR J. 2001;42(3):233-47. (Pubitemid 33708711)
107. Tremoleda JL, Kerton A, Gsell W. Anaesthesia and physiological monitoring during in vivo imaging of laboratory rodents: considerations on experimental outcomes and animal welfare. EJNMMI Res. 2012;2(1):44.
108. Skresanova IV, Barannik EA. Correlation functions and power spectra of Doppler response signals in ultrasonic medical applications. Ultrasonics. 2012;52(5):676-84.
109. Deshpande N, Needles A, Willmann JK. Molecular ultrasound imaging: current status and future directions. Clin Radiol. 2010;65(7):567-81.
110. Greco A, Mancini M, Gargiulo S, Gramanzini M, Claudio PP, Brunetti A, et al. Ultrasound biomicroscopy in small animal research: applications in molecular and preclinical imaging. J Biomed Biotechnol. 2012;2012:519238.
111. Golden HB, Sunder S, Liu Y, Peng X, Dostal DE. In utero assessment of cardiovascular function in the embryonic mouse heart using high-resolution ultrasound biomicroscopy. Method Mol Biol. 2012;843:245-63.
112. Cheung AM, Brown AS, Cucevic V, Roy M, Needles A, Yang V, et al. Detecting vascular changes in tumour xenografts using micro-ultrasound and micro-ct following treatment with VEG-FR-2 blocking antibodies. Ultrasound Med Biol. 2007;33(8):1259-68. (Pubitemid 47102516)
113. Kaufmann BA, Lankford M, Behm CZ, French BA, Klibanov AL, Xu Y, et al. High-resolution myocardial perfusion imaging in mice with high-frequency echocardiographic detection of a depot contrast agent. J Am Soc Echocardiogr. 2007;20(2):136-43. (Pubitemid 46176567)
114. Alves KZ, Soletti RC, de Britto MA, de Matos DG, Soldan M, Borges HL, et al. In Vivo endoluminal ultrasound biomicroscopic imaging in a mouse model of colorectal cancer. Acad Radiol. 2013;20(1):90-8.
115. Alexandrakis G, Rannou FR, Chatziioannou AF. Effect of optical property estimation accuracy on tomographic bioluminescence imaging: simulation of a combined optical-PET (OPET) system. Phys Med Biol. 2006;51(8):2045-53.
116. Peter J, Ruehle H, Stamm V, Schulz RB, Smith MF, Welch B, et al. Development and initial results of a dual-modality SPECT/optical small animal imager. Nuclear Science Symposium Conference Record; 2005 IEEE; 2005 23-29 Oct: p. 4.
117. Hyde D, de Kleine R, MacLaurin SA, Miller E, Brooks DH, Krucker T, et al. Hybrid FMT-CT imaging of amyloid-beta plaques in a murine Alzheimer's disease model. Neuroimage. 2009;44(4):1304-11.
118. Wen Z, Fahrig R, Williams ST, Pelc NJ. Shimming with permanent magnets for the x-ray detector in a hybrid x-ray/ MR system. Med Phys. 2008;35(9):3895-902.
119. Gulsen G, Birgul O, Unlu MB, Shafiiha R, Nalcioglu O. Combined diffuse optical tomography (DOT) and MRI system for cancer imaging in small animals. Technol Cancer Res Treat. 2006;5(4):351-63. (Pubitemid 44313706)
120. Kundu BK, Stolin AV, Pole J, Baumgart L, Fontaine M, Wojcik R, et al. Tri-modality small animal imaging system. IEEE Trans Nucl Sci. 2006;53(1):66-70.
121. Veit-Haibach P, Kuhn FP, Wiesinger F, Delso G, von Schulthess G. PET-MR imaging using a tri-modality PET/CT-MR system with a dedicated shuttle in clinical routine. MAGMA. 2013; 26(1):25-35.
122. Tsukamoto E, Ochi S. PET/CT today: system and its impact on cancer diagnosis. Ann Nucl Med. 2006;20(4):255-67. (Pubitemid 44033266)
123. Bergeron M, Cadorette J, Beaudoin JF, Lepage MD, Robert G, Selivanov V, et al. Performance evaluation of the LabPET APDbased digital PET scanner. IEEE Trans Nucl Sci. 2009;56(1):10-6.
124. Levin Klausen T, Hogild Keller S, Vinter Olesen O, Aznar M, Andersen FL. Innovations in PET/CT. Q J Nucl Med Mol Imaging. 2012;56(3):268-79.
125. Beyer T, Freudenberg LS, Townsend DW, Czernin J. The future of hybrid imaging-part 1: hybrid imaging technologies and SPECT/CT. Insight Imaging. 2011;2(2):161-9.
126. Hammer BE, Christensen NL, Heil BG. Use of a magnetic field to increase the spatial resolution of positron emission tomography. Med Phys. 1994;21(12):1917-20.
127. Beyer T, Freudenberg LS, Czernin J, Townsend DW. The future of hybrid imaging-part 3: PET/MR, small-animal imaging and beyond. Insight Imaging. 2011;2(3):235-46.
128. Wirrwar A, Vosberg H, Herzog H, Halling H, Weber S, MullerGartner HW. 4.5 Tesla magnetic field reduces range of high-energy positrons-potential implications for positron emission tomography. IEEE Trans Nucl Sci. 1997;44(2):184-9. (Pubitemid 127762130)
129. Cherry SR. Multimodality imaging: beyond PET/CT and SPECT/CT. Semin Nucl Med. 2009;39(5):348-53.
130. Wagenknecht G, Kaiser HJ, Mottaghy FM, Herzog H. MRI for attenuation correction in PET: methods and challenges. MAGMA. 2013;26(1):99-113.
131. Tartis MS, Kruse DE, Zheng H, Zhang H, Kheirolomoom A, Marik J, et al. Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. J Controlled Release. 2008; 131(3):160-6.
132. Markets, Markets. Small Animal Imaging (In Vivo) Market: Competitive Analysis & Global Forecasts to 2017. 2012 [cited 16 Feb 2013]. http://www.companiesandmarkets.com/Market/Healthcare-and-Medical/ Market-Research/Small-Animal-Imaging-In-Vivo-Market-Competitive-Analysis-Global- Forecasts-to-2017/RPT1134167.
133. Balcerzyk M, Kontaxakis G, Delgado M, Garcia-Garcia L, Correcher C, Gonzalez AJ, et al. Initial performance evaluation of a high resolution Albira small animal positron emission tomography scanner with monolithic crystals and depth-ofinteraction encoding from a user's perspective. Measurement Sci Technol. 2009;20(10).
134. Szanda I, Mackewn J, Patay G, Major P, Sunassee K, Mullen GE, et al. National electrical manufacturers association NU-4 performance evaluation of the PET component of the NanoPET/CT preclinical PET/CT Scanner. J Nucl Med. 2011;52(11):1741-7.
135. Goorden MC, van der Have F, Kreuger R, Ramakers RM, Vastenhouw B, Burbach JP, et al. VECTor: a preclinical imaging system for simultaneous submillimeter SPECT and PET. J Nucl Med. 2013;54(2):306-12.
136. Goertzen AL, Bao QN, Bergeron M, Blankemeyer E, Blinder S, Canadas M, et al. NEMA NU 4-2008 comparison of preclinical PET imaging systems. J Nucl Med. 2012;53(8):1300-9.
137. Bao Q, Newport D, Chen M, Stout DB, Chatziioannou AF. Performance evaluation of the inveon dedicated PET preclinical tomograph based on the NEMA NU-4 standards. J Nucl Med. 2009;50(3):401-8.
138. Herrmann K, Dahlbom M, Nathanson D, Wei L, Radu C, Chatziioannou A, et al. Evaluation of the Genisys4, a bench-top preclinical PET scanner. J Nucl Med. 2013;54(7):1162-7.